Anika Therapeutics, Inc. (ANIK) stock
ANIKNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
$13.23−0.05 (-0.38%)
Close on Nov 20, 2026Market cap $177.06MP/E –Yield –
Anika Therapeutics free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Anika Therapeutics's free cash flow for the twelve months ending Jun 30, 2026 was $562.00K. For fiscal 2025 it was $4.36M. Over ten years it grew -17.7% a year on average. The highest annual figure on record is $38.43M in fiscal 2014.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.36M | – |
| FY2024 | Dec 31, 2024 | -$2.33M | – |
| FY2023 | Dec 31, 2023 | -$7.22M | – |
| FY2022 | Dec 31, 2022 | -$3.08M | -194.6% |
| FY2021 | Dec 31, 2021 | $3.25M | -71.5% |
| FY2020 | Dec 31, 2020 | $11.44M | -66.5% |
| FY2019 | Dec 31, 2019 | $34.18M | +12.9% |
| FY2018 | Dec 31, 2018 | $30.26M | -4.9% |
| FY2017 | Dec 31, 2017 | $31.83M | +205.1% |
| FY2016 | Dec 31, 2016 | $10.43M | -66.0% |
| FY2015 | Dec 31, 2015 | $30.69M | -20.1% |
| FY2014 | Dec 31, 2014 | $38.43M | +55.4% |
| FY2013 | Dec 31, 2013 | $24.72M | +173.4% |
| FY2012 | Dec 31, 2012 | $9.04M | +3.1% |
| FY2011 | Dec 31, 2011 | $8.77M | +73.1% |
| FY2010 | Dec 31, 2010 | $5.07M | – |
| FY2009 | Dec 31, 2009 | -$867.53K | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$2.13M | – |
| Q1 FY2026 | Mar 31, 2026 | -$6.28M | – |
| Q4 FY2025 | Dec 31, 2025 | $3.99M | +1350.5% |
| Q3 FY2025 | Sep 30, 2025 | $4.98M | +31.1% |
| Q2 FY2025 | Jun 30, 2025 | -$1.66M | – |
| Q1 FY2025 | Mar 31, 2025 | -$2.95M | – |
| Q4 FY2024 | Dec 31, 2024 | $275.00K | -84.7% |
| Q3 FY2024 | Sep 30, 2024 | $3.80M | -33.8% |
| Q2 FY2024 | Jun 30, 2024 | -$4.47M | – |
| Q1 FY2024 | Mar 31, 2024 | -$1.93M | – |
| Q4 FY2023 | Dec 31, 2023 | $1.80M | – |
| Q3 FY2023 | Sep 30, 2023 | $5.74M | +464.2% |
| Q2 FY2023 | Jun 30, 2023 | -$9.75M | -949.3% |
| Q1 FY2023 | Mar 31, 2023 | -$5.01M | – |
| Q4 FY2022 | Dec 31, 2022 | -$2.05M | -161.2% |
| Q3 FY2022 | Sep 30, 2022 | $1.02M | +30.8% |
| Q2 FY2022 | Jun 30, 2022 | $1.15M | -42.0% |
| Q1 FY2022 | Mar 31, 2022 | -$3.20M | – |
| Q4 FY2021 | Dec 31, 2021 | $3.35M | +56.5% |
| Q3 FY2021 | Sep 30, 2021 | $778.00K | -86.1% |
| Q2 FY2021 | Jun 30, 2021 | $1.98M | -41.5% |
| Q1 FY2021 | Mar 31, 2021 | -$2.85M | -984.5% |
| Q4 FY2020 | Dec 31, 2020 | $2.14M | -83.2% |
| Q3 FY2020 | Sep 30, 2020 | $5.59M | -41.9% |
| Q2 FY2020 | Jun 30, 2020 | $3.38M | -22.6% |
| Q1 FY2020 | Mar 31, 2020 | $322.00K | -95.7% |
| Q4 FY2019 | Dec 31, 2019 | $12.75M | +29.5% |
| Q3 FY2019 | Sep 30, 2019 | $9.62M | -0.1% |
| Q2 FY2019 | Jun 30, 2019 | $4.37M | +17.1% |
| Q1 FY2019 | Mar 31, 2019 | $7.43M | +5.4% |
| Q4 FY2018 | Dec 31, 2018 | $9.85M | +118.5% |
| Q3 FY2018 | Sep 30, 2018 | $9.63M | +1.3% |
| Q2 FY2018 | Jun 30, 2018 | $3.73M | -7.4% |
| Q1 FY2018 | Mar 31, 2018 | $7.05M | -48.9% |
| Q4 FY2017 | Dec 31, 2017 | $4.51M | -3.4% |
| Q3 FY2017 | Sep 30, 2017 | $9.51M | +10.9% |
| Q2 FY2017 | Jun 30, 2017 | $4.03M | – |
| Q1 FY2017 | Mar 31, 2017 | $13.79M | – |
| Q4 FY2016 | Dec 31, 2016 | $4.66M | – |
| Q3 FY2016 | Sep 30, 2016 | $8.58M | – |
See a number that looks wrong?